NO892828L - Fremgangsmaate ved fremstilling av piperidinderivater. - Google Patents

Fremgangsmaate ved fremstilling av piperidinderivater.

Info

Publication number
NO892828L
NO892828L NO89892828A NO892828A NO892828L NO 892828 L NO892828 L NO 892828L NO 89892828 A NO89892828 A NO 89892828A NO 892828 A NO892828 A NO 892828A NO 892828 L NO892828 L NO 892828L
Authority
NO
Norway
Prior art keywords
preparing
procedure
chem
formula
group
Prior art date
Application number
NO89892828A
Other languages
English (en)
Norwegian (no)
Other versions
NO892828D0 (no
Inventor
David Alker
Peter Edward Cross
Robert Michael Wallis
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO892828D0 publication Critical patent/NO892828D0/no
Publication of NO892828L publication Critical patent/NO892828L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO89892828A 1988-07-08 1989-07-07 Fremgangsmaate ved fremstilling av piperidinderivater. NO892828L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888816365A GB8816365D0 (en) 1988-07-08 1988-07-08 Therapeutic agents

Publications (2)

Publication Number Publication Date
NO892828D0 NO892828D0 (no) 1989-07-07
NO892828L true NO892828L (no) 1990-01-09

Family

ID=10640168

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89892828A NO892828L (no) 1988-07-08 1989-07-07 Fremgangsmaate ved fremstilling av piperidinderivater.

Country Status (28)

Country Link
US (1) US5089505A (da)
EP (1) EP0350309B1 (da)
JP (2) JPH0739388B2 (da)
KR (1) KR930002728B1 (da)
CN (1) CN1022914C (da)
AT (1) ATE82262T1 (da)
AU (1) AU602453B2 (da)
CA (1) CA1336833C (da)
DD (1) DD284011A5 (da)
DE (1) DE68903437T2 (da)
DK (1) DK337589A (da)
EG (1) EG18853A (da)
ES (1) ES2052917T3 (da)
FI (1) FI94241C (da)
GB (1) GB8816365D0 (da)
GR (1) GR3006595T3 (da)
HU (1) HUT50771A (da)
IE (1) IE63438B1 (da)
IL (1) IL90792A0 (da)
MX (1) MX16728A (da)
MY (1) MY106976A (da)
NO (1) NO892828L (da)
NZ (1) NZ229865A (da)
PL (2) PL162318B1 (da)
PT (1) PT91081B (da)
RU (2) RU1838307C (da)
YU (1) YU135389A (da)
ZA (1) ZA895175B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231104A (en) * 1988-07-08 1993-07-27 Pfizer Inc. 1-arylethyl-3-substituted piperidines
GB9000301D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Piperidine & pyrrolidine derivatives
GB9208230D0 (en) * 1992-04-14 1992-05-27 Pfizer Ltd Treatment of delayed gastric emptying
US5340826A (en) * 1993-02-04 1994-08-23 Pfizer Inc. Pharmaceutical agents for treatment of urinary incontinence
GB9400600D0 (en) * 1994-01-14 1994-03-09 Pfizer Ltd Treatment of motion seckness
US6331541B1 (en) 1998-12-18 2001-12-18 Soo S. Ko N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
CA2348923A1 (en) 1998-12-18 2000-06-22 Dean A. Wacker N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU770042B2 (en) * 1998-12-18 2004-02-12 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6525069B1 (en) 1998-12-18 2003-02-25 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
WO2000035449A1 (en) * 1998-12-18 2000-06-22 Du Pont Pharmaceuticals Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6897234B2 (en) 1999-12-17 2005-05-24 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AR034257A1 (es) 2000-06-30 2004-02-18 Du Pont Pharm Co Compuesto ureido, composicion farmaceutica que lo comprende y metodo para modular la actividad del receptor de quimiocinas
AU9087301A (en) * 2000-09-11 2002-03-26 Sepracor Inc Ligands for monoamine receptors and transporters, and methods of use thereof
US6508872B2 (en) * 2001-02-26 2003-01-21 Hewlett-Packard Company Lightfast additive molecule for inkjet ink
US20090005309A1 (en) * 2007-05-18 2009-01-01 Auspex Pharmaceuticals, Inc. Substituted piperidines
WO2011148888A1 (ja) * 2010-05-27 2011-12-01 あすか製薬株式会社 複素環化合物及びh1受容体拮抗剤
CN107129453B (zh) * 2016-02-26 2019-10-11 中国科学院大连化学物理研究所 化合物、毒蕈碱m受体拮抗剂、组合物及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA541598A (en) * 1957-05-28 Levy Joseph N-substituted-4-benzhydryl etherpiperidines and method for obtaining the same
GB688345A (en) * 1951-02-19 1953-03-04 Greenwood And Hughes Ltd Improvements in sanitary liquid traps
US2745837A (en) * 1954-01-21 1956-05-15 Schering Corp Benzhydryl ethers of alkyl piperidinols
GB780027A (en) * 1955-01-20 1957-07-31 Schering Corp 3-piperidyl ethers and thioethers
US2974146A (en) * 1956-02-24 1961-03-07 Lakeside Lab Inc 3-piperidyl benzhydryl ethers
NL237664A (da) * 1959-04-01

Also Published As

Publication number Publication date
PT91081B (pt) 1995-01-31
EG18853A (en) 1994-12-30
MX16728A (es) 1993-08-01
MY106976A (en) 1995-08-30
KR930002728B1 (ko) 1993-04-09
AU602453B2 (en) 1990-10-11
AU3797189A (en) 1990-02-15
FI893326A0 (fi) 1989-07-07
GR3006595T3 (da) 1993-06-30
US5089505A (en) 1992-02-18
FI94241B (fi) 1995-04-28
DK337589A (da) 1990-01-09
PT91081A (pt) 1990-02-08
JPH0739388B2 (ja) 1995-05-01
RU1836364C (ru) 1993-08-23
PL162318B1 (pl) 1993-09-30
DD284011A5 (de) 1990-10-31
CN1039415A (zh) 1990-02-07
ATE82262T1 (de) 1992-11-15
EP0350309B1 (en) 1992-11-11
IE63438B1 (en) 1995-04-19
IL90792A0 (en) 1990-01-18
DE68903437D1 (de) 1992-12-17
JPH0276851A (ja) 1990-03-16
IE892202L (en) 1990-01-08
ES2052917T3 (es) 1994-07-16
CA1336833C (en) 1995-08-29
FI94241C (fi) 1995-08-10
GB8816365D0 (en) 1988-08-10
DE68903437T2 (de) 1993-03-25
DK337589D0 (da) 1989-07-07
EP0350309A1 (en) 1990-01-10
JPH07157469A (ja) 1995-06-20
FI893326A (fi) 1990-01-09
HUT50771A (en) 1990-03-28
ZA895175B (en) 1991-02-27
KR900001683A (ko) 1990-02-27
NO892828D0 (no) 1989-07-07
YU135389A (en) 1991-06-30
RU1838307C (ru) 1993-08-30
NZ229865A (en) 1991-01-29
CN1022914C (zh) 1993-12-01
PL161887B1 (pl) 1993-08-31

Similar Documents

Publication Publication Date Title
NO892828D0 (no) Fremgangsmaate ved fremstilling av piperidinderivater.
NZ331457A (en) Methoxybenzophenone compounds, a process for their preparation and a method involving them for combating fungal growth
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
AU635779B2 (en) 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
DE69428882D1 (de) Verwendung von Raloxifen und dessen Analogen zur Herstellung eines Medikaments zur Behandlung von Atherosklerose und ischämischer Herzerkrankungen
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
DK0652004T3 (da) Fremgangsmåder til behandling af resistente neoplasmer
ATE173252T1 (de) Arylmorpholine, herstellung und verwendung
BR9406996A (pt) Enanciômero processo para preparar o mesmo processo para ciclizar um composto e composto intermediário
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.